Durham NC 食管腺癌临床试验
10项针对 食管腺癌的研究正在 Durham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
招募中3 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距离 10 英里
- University of North Carolina-Hillsborough Campus, Hillsborough · 距离 13 英里
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
招募中2/3 期
- University of North Carolina Medical Center, Chapel Hill · 距离 10 英里
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
招募中2 期
- Duke University Medical Center, Durham
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
招募中欢迎健康志愿者
- University of North Carolina at Chapel Hill, Chapel Hill · 距离 10 英里
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
招募中2 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距离 10 英里
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
招募中
- University of North Carolina School of Medicine, Chapel Hill · 距离 10 英里
Obeticholic Acid for Prevention in Barrett's Esophagus
招募中2 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距离 10 英里
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
招募中
- University of North Carolina at Chapel Hill, Chapel Hill · 距离 10 英里
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
招募中1 期
- Research Site, Durham
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
招募中2 期
- Durham VA Medical Center, Durham, NC, Durham
其他城市的 食管腺癌试验
- New York City, NY18 项研究
- Boston, MA13 项研究
- Houston, TX12 项研究
- Arlington, VA11 项研究
- Nashville, TN11 项研究
- Jacksonville, FL9 项研究
- Rochester, MN9 项研究
- Baldwin Park, CA9 项研究
- St. Louis, MO9 项研究
- Queens, NY9 项研究
- Los Angeles, CA9 项研究
- Dallas, TX8 项研究
Durham的其他研究
- 乳腺癌64 项研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌39 项研究
- 多发性骨髓瘤37 项研究
- 急性髓系白血病33 项研究
- 转移性癌症33 项研究
- 前列腺癌32 项研究
- 肺癌32 项研究
- 结直肠癌28 项研究
- 卵巢癌27 项研究
- 慢性淋巴细胞白血病27 项研究
- 心力衰竭26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。